C2 Therapeutics raises $11.6 million in the wake of FDA clearance for its esophageal ablation device.
C2 Therapeutics raised $11.6 million in equity funding, according to a recent regulatory filing.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1wB5CPL
Cap comentari:
Publica un comentari a l'entrada